Clinical trials
Phase 2 Lymphoma, Mantle-Cell trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 7 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Celgene | 2 |
| University College, London | 2 |
| Acerta Pharma BV | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Incyte Corporation | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Janssen Research & Development, LLC | 1 |
| Kite, A Gilead Company | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 17 |
| Lymphoma | 7 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Recurrence | 2 |
| Blood Protein Disorders | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.